Vertical transmission of hepatitis B virus: propositions and future directions
Open Access
- 11 October 2021
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 134 (23), 2825-2831
- https://doi.org/10.1097/cm9.0000000000001800
Abstract
Chronic hepatitis B virus (HBV) infection due to vertical transmission remains a critical concern with regards to eliminating HBV infection. Implementation of hepatitis B vaccine, the foundation to prevent perinatal and horizontal transmission, has reduced the prevalence of HBV by >80%. In countries where the hepatitis B immune globulin (HBIG) is available, such as China and the United States, the administration of HBIG and hepatitis B vaccine to the infants of mothers who are positive for hepatitis B surface antigen has become a standard practice and is effective in preventing vertical transmission. Accumulating evidence on the efficacy and safety of antiviral prophylaxis during pregnancy indicates the probability of attaining the goal of the World Health Organization to eliminate hepatitis by 2030. In this review, we discuss the transmission routes, diagnostic criteria, and preventive strategies for vertical transmission. A preventive program that includes screening before pregnancy, antiviral prophylaxis during pregnancy, and postpartum immunoprophylaxis provides “perfect strategies” to eliminate vertical transmission. However, there is still a notable gap between “perfect strategies” and real-world application, including insufficient coverage of timely birth dose vaccine and the efficacy and necessity of HBIG, especially in mothers who are negative for hepatitis B envelope antigen. In particular, there is a clear need for a comprehensive long-term safety profile of antiviral prophylaxis. Therefore, feasible and cost-effective preventive strategies need to be determined across regions. Access also needs to be scaled up to meet the demands for prophylaxis and prevalence targets.Keywords
This publication has 51 references indexed in Scilit:
- Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for interventionJournal of Hepatology, 2013
- Cost-effectiveness of Augmenting Universal Hepatitis B Vaccination With Immunoglobin TreatmentPEDIATRICS, 2013
- Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale InvestigationPLOS ONE, 2012
- Relationship between HBV cccDNA expression in the human ovary and vertical transmission of HBVEpidemiology and Infection, 2011
- Breastfeeding of Newborns by Mothers Carrying Hepatitis B VirusArchives of Pediatrics & Adolescent Medicine, 2011
- Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothersJournal of Viral Hepatitis, 2011
- A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infectionJournal of Hepatology, 2011
- Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infantsJournal of Viral Hepatitis, 2010
- Presence of HBsAg, HBcAg, and HBVDNA in ovary and ovum of the patients with chronic hepatitis B virus infectionAmerican Journal of Obstetrics and Gynecology, 2006
- Assessment of the Target-Capture PCR Hepatitis B Virus (HBV) DNA Quantitative Assay and Comparison with Commercial HBV DNA Quantitative AssaysJournal of Clinical Microbiology, 2004